Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Move amid evidence of widespread reporting gaps
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Paves the way for next-gen ultra-precise gas sensing
Scientists at the forum warned of an increasingly volatile health landscape
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Subscribe To Our Newsletter & Stay Updated
